Table 2 Clinical features of the neonates underwent surgery
Case A | Case B | Case C | Case D | Case E | |
|---|---|---|---|---|---|
Gender | F | M | F | M | F |
GA(W) | 27+ 2 | 27 | 30+ 3 | 30 | 24+ 3 |
BW(g) | 1000 | 1060 | 1400 | 1130 | 640 |
Antenatal steroid | + | + | – | + | + |
Max Milk intake (ml/kg/d) | 15.3 | 0.5 | 1.5 | 4 | 1 |
Antenatal infection | + | + | – | – | – |
Vaginal/CS | V | V | CS | CS | V |
Asphyxia at birth | – | – | – | – | – |
Res support | nIMV | nCPAP | Hiflow | nIMV | SIMV |
WBC(×10^9/l) | 14.4 | 11.5 | 9.4 | 12.6 | 38.3 |
Neutrophil (%) | 62.5 | 65.6 | 35.2 | 49 | 71.3 |
CRP (mg/L) | 175 | 0.5 | < 1 | < 0.5 | 3.03 |
Postnatal day of discovering perforation | 39 | 3 | 3 | 9 | 8 |
Postnatal day of transferring to surgery | 39 | 3 | 3 | 31 | 45 |
Pathology | NEC | SIP | GP | Intestinal obstruction after perforation | Intestinal obstruction after perforation |
Result of surgery | Abandoned treatment during operation | improved | improved | improved | improved |